Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

Malignant pleural effusion (MPE) is one of the common complications of lung cancer. The quality of life and prognoses for MPE patients are significantly compromised. Controlling the production of MPE can relieve patients’ symptoms, improve their quality of life, and prolong their survival. This arti...

Full description

Bibliographic Details
Main Authors: Changhong Dong, Chenxi Hu, Yanting Jiang, Kaiyuan Hui, Xiaodong Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
malignant pleural effusion
immune checkpoint inhibitors
anti-angiogenic therapy
envafolimab
Endostar
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1368059/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1368059/full

Similar Items